A detailed history of Citigroup Inc transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Citigroup Inc holds 1,537,803 shares of BBIO stock, worth $43.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,537,803
Previous 1,315,339 16.91%
Holding current value
$43.9 Million
Previous $33.3 Million 17.51%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$23.91 - $31.3 $5.32 Million - $6.96 Million
222,464 Added 16.91%
1,537,803 $39.2 Million
Q2 2024

Aug 12, 2024

SELL
$23.0 - $31.04 $10.9 Million - $14.7 Million
-474,731 Reduced 26.52%
1,315,339 $33.3 Million
Q1 2024

May 10, 2024

BUY
$27.35 - $40.45 $6.37 Million - $9.42 Million
232,839 Added 14.95%
1,790,070 $55.3 Million
Q4 2023

Feb 09, 2024

SELL
$24.02 - $43.89 $729,271 - $1.33 Million
-30,361 Reduced 1.91%
1,557,231 $62.9 Million
Q3 2023

Nov 09, 2023

BUY
$16.89 - $35.01 $2.7 Million - $5.6 Million
160,076 Added 11.21%
1,587,592 $41.9 Million
Q2 2023

Aug 10, 2023

SELL
$13.29 - $18.01 $1.59 Million - $2.15 Million
-119,529 Reduced 7.73%
1,427,516 $24.6 Million
Q1 2023

May 11, 2023

BUY
$7.17 - $18.55 $1.16 Million - $3.01 Million
162,116 Added 11.71%
1,547,045 $25.7 Million
Q4 2022

Feb 09, 2023

SELL
$6.74 - $11.52 $910,789 - $1.56 Million
-135,132 Reduced 8.89%
1,384,929 $10.6 Million
Q3 2022

Nov 10, 2022

BUY
$7.94 - $12.36 $362,532 - $564,345
45,659 Added 3.1%
1,520,061 $15.1 Million
Q2 2022

Aug 10, 2022

BUY
$5.21 - $12.14 $1.79 Million - $4.17 Million
343,362 Added 30.36%
1,474,402 $13.4 Million
Q1 2022

May 12, 2022

SELL
$7.34 - $17.16 $596,727 - $1.4 Million
-81,298 Reduced 6.71%
1,131,040 $11.5 Million
Q4 2021

Feb 10, 2022

BUY
$11.38 - $53.41 $8.37 Million - $39.3 Million
735,295 Added 154.14%
1,212,338 $20.2 Million
Q3 2021

Nov 10, 2021

BUY
$46.87 - $64.24 $22.4 Million - $30.6 Million
477,043 New
477,043 $22.4 Million

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $4.23B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.